Search all medical codes

Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, urinary tract, 1 ml, includes shipping and necessary supplies

HCPCS code

Name of the Procedure:

Injectable Bulking Agent, Dextranomer/Hyaluronic Acid Copolymer Implant, Urinary Tract (L8604)

  • Common name(s): Urethral Bulking Agent Injection
  • Medical term: Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, urinary tract

Summary

This procedure involves injecting a gel-like substance into the urinary tract to help treat conditions like urinary incontinence. The injectable material is a combination of dextranomer and hyaluronic acid, which works to provide extra support to the tissues in the urinary tract.

Purpose

Medical Conditions:

  • Stress urinary incontinence (SUI)
  • Weakness or damage in the tissues supporting the urethra

Goals/Outcomes:

  • Strengthen the tissues in the urinary tract
  • Improve bladder control
  • Reduce or eliminate episodes of urinary incontinence

Indications

Symptoms:

  • Frequent accidental leakage of urine, especially during physical activities like coughing, sneezing, or exercising

Patient Criteria:

  • Patients who have not responded well to conservative treatments like pelvic floor exercises or medications
  • Patients seeking a minimally invasive option

Preparation

Pre-procedure Instructions:

  • Patients may be advised to stop taking certain medications like blood thinners
  • Fasting may be required if sedation or anesthesia will be used

Diagnostic Tests:

  • Urinalysis to rule out infections
  • Urodynamic studies to assess bladder function

Procedure Description

  1. Prepping: The patient is positioned appropriately, and the urinary tract area is cleaned and prepped.
  2. Anesthesia: Local anesthesia is usually administered to numb the area.
  3. Injection: Using a cystoscope (a thin tube with a camera), the doctor injects the bulking agent into the tissue surrounding the urethra.
  4. Completion: The cystoscope is removed, and the patient is monitored for a short period before discharge.

Tools/Equipment:

  • Cystoscope
  • Syringe with dextranomer/hyaluronic acid copolymer gel

Duration

The procedure typically takes about 30 minutes to an hour.

Setting

Performed in:

  • Outpatient clinic
  • Hospital setting
  • Surgical center

Personnel

Healthcare professionals involved:

  • Urologist or specialized physician
  • Nurse
  • Anesthesiologist (if sedation is used)

Risks and Complications

Common Risks:

  • Mild pain at the injection site
  • Temporary difficulty with urination

Rare Risks:

  • Infection
  • Allergic reaction to the bulking agent
  • Urinary retention

Benefits

Expected Benefits:

  • Significant reduction in urine leakage
  • Improvement in quality of life

Timeline:

  • Benefits can often be noticed within a few weeks after the procedure

Recovery

Post-procedure Care:

  • Patients can usually go home the same day
  • Avoid strenuous activities for a few days
  • Drink plenty of water to help flush the bladder

Recovery Time:

  • Most people can return to normal activities within a few days
  • Follow-up appointments may be required to check on progress

Alternatives

Other Treatment Options:

  • Pelvic floor exercises (Kegel exercises)
  • Medications
  • Surgical options like sling procedures

Pros and Cons of Alternatives:

  • Exercises and medications are less invasive but might be less effective for some patients
  • Surgical options are more invasive but may offer a more permanent solution

Patient Experience

During Procedure:

  • Mild discomfort or pressure during the injection
  • Minimal to moderate pain if local anesthesia is used

After Procedure:

  • Temporary soreness in the treated area
  • Instructions will be provided for pain management and comfort, like localized ice packs or prescribed pain relievers

Similar Codes